Flagship Pioneering Fund VI, L.P.
10% owner at Generate Biomedicines.
- Rank
- 642nd of 809
- Companies held
- 1
- Largest holding
- GENB, 100.0% of total
- Latest SEC filing
- Mar 2, 2026
- Listed but not counted
- $374M
What the $94.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Generate Biomedicines GENB Common Stock | Through Flagship VentureLabs VI, LLC Reported jointly by 3 insiders; split evenly | 8,338,819 | $10.37 | $86.5M | 91.4% | Form 4, Feb 26, 2026 |
| Generate Biomedicines GENB Common Stock | Through Pioneering Medicines 02, LLC Reported jointly by 2 insiders; split evenly | 781,250 | $10.37 | $8.1M | 8.6% | Form 4, Mar 2, 2026 |
Share counts are the amounts Flagship Pioneering Fund VI, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Flagship Pioneering Fund VI, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Generate Biomedicines GENB Common Stock | Through Flagship Pioneering Fund VII, L.P. Held by a company or fund the insider manages | 15,264,724 | $10.37 | $158M | — | Form 4, Mar 2, 2026 |
| Generate Biomedicines GENB Common Stock | Through Flagship Pioneering Fund VI, L.P. Held by an investment fund or partnership | 12,723,940 | $10.37 | $132M | — | Form 4, Mar 2, 2026 |
| Generate Biomedicines GENB Common Stock | Through FPN II, L.P. Held by a company or fund the insider manages | 4,340,252 | $10.37 | $45.0M | — | Form 4, Mar 2, 2026 |
| Generate Biomedicines GENB Common Stock | Through Flagship Pioneering Special Opportunities Fund II, L.P. Held by a company or fund the insider manages | 2,777,752 | $10.37 | $28.8M | — | Form 4, Mar 2, 2026 |
| Generate Biomedicines GENB Common Stock | Through Nutritional Health LTP Fund, L.P. Held by a company or fund the insider manages | 987,491 | $10.37 | $10.2M | — | Form 4, Mar 2, 2026 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 639 | Diana Shipping Inc. 10% owner, Genco Shipping & Trading | $96.2M |
| 640 | Fhmls Xi, L.P. 10% owner, Attovia Therapeutics | $95.9M |
| 641 | Nutritional Health LTP Fund General Partner LLC 10% owner, Generate Biomedicines | $94.6M |
| 642 | Flagship Pioneering Fund VI, L.P. 10% owner, Generate Biomedicines | $94.6M |
| 643 | DME Advisors GP, L.L.C. Director, Green Brick Partners | $94.2M |
| 644 | DME Advisors, LP Director, Green Brick Partners | $94.2M |
| 645 | Brookfield Oaktree Holdings, LLC 10% owner, Expand Energy | $94.2M |
Other Generate Biomedicines insiders
All GENB insiders- Michael Nally$30.0MChief Executive Officer. #3785 overall
- Gevorg Grigoryan$6.8MChief Technology Officer. #11590 overall
- Stephane Bancel$4.8MDirector. #211 overall
- Frances Arnold$4.7MDirector. #6760 overall
Questions
How much stock does Flagship Pioneering Fund VI, L.P. own?
Flagship Pioneering Fund VI, L.P. holds $94,575,119 in listed stock based on SEC filings and current prices, mostly Generate Biomedicines (GENB). That ranks 642nd on the Stock Rich List.
Is this Flagship Pioneering Fund VI, L.P.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Flagship Pioneering Fund VI, L.P. last buy or sell stock?
The most recent open-market trade on file is a purchase of 1,562,500 GENB shares on Mar 2, 2026 at $16.00.
Files jointly with Noubar B. Afeyan.